Unknown

Dataset Information

0

Targeting the Hsp90 C-terminal domain to induce allosteric inhibition and selective client downregulation.


ABSTRACT: BACKGROUND:Inhibition of Hsp90 is desirable due to potential downregulation of oncogenic clients. Early generation inhibitors bind to the N-terminal domain (NTD) but C-terminal domain (CTD) inhibitors are a promising class because they do not induce a heat shock response. Here we present a new structural class of CTD binding molecules with a unique allosteric inhibition mechanism. METHODS:A hit molecule, NSC145366, and structurally similar probes were assessed for inhibition of Hsp90 activities. A ligand-binding model was proposed indicating a novel Hsp90 CTD binding site. Client protein downregulation was also determined. RESULTS:NSC145366 interacts with the Hsp90 CTD and has anti-proliferative activity in tumor cell lines (GI50=0.2-1.9?M). NSC145366 increases Hsp90 oligomerization resulting in allosteric inhibition of NTD ATPase activity (IC50=119?M) but does not compete with NTD or CTD-ATP binding. Treatment of LNCaP prostate tumor cells resulted in selective client protein downregulation including AR and BRCA1 but without a heat shock response. Analogs had similar potencies in ATPase and chaperone activity assays and variable effects on oligomerization. In silico modeling predicted a binding site at the CTD dimer interface distinct from the nucleotide-binding site. CONCLUSIONS:A set of symmetrical scaffold molecules with bisphenol A cores induced allosteric inhibition of Hsp90. Experimental evidence and molecular modeling suggest that the binding site is independent of the CTD-ATP site and consistent with unique induction of allosteric effects. GENERAL SIGNIFICANCE:Allosteric inhibition of Hsp90 via a mechanism used by the NSC145366-based probes is a promising avenue for selective oncogenic client downregulation.

SUBMITTER: Goode KM 

PROVIDER: S-EPMC6453127 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting the Hsp90 C-terminal domain to induce allosteric inhibition and selective client downregulation.

Goode Kourtney M KM   Petrov Dino P DP   Vickman Renee E RE   Crist Scott A SA   Pascuzzi Pete E PE   Ratliff Tim L TL   Davisson V Jo VJ   Hazbun Tony R TR  

Biochimica et biophysica acta. General subjects 20170508 8


<h4>Background</h4>Inhibition of Hsp90 is desirable due to potential downregulation of oncogenic clients. Early generation inhibitors bind to the N-terminal domain (NTD) but C-terminal domain (CTD) inhibitors are a promising class because they do not induce a heat shock response. Here we present a new structural class of CTD binding molecules with a unique allosteric inhibition mechanism.<h4>Methods</h4>A hit molecule, NSC145366, and structurally similar probes were assessed for inhibition of Hs  ...[more]

Similar Datasets

| S-EPMC6097425 | biostudies-literature
| S-EPMC5921262 | biostudies-literature
| S-EPMC8682993 | biostudies-literature
| S-EPMC7575213 | biostudies-literature
| S-EPMC10297700 | biostudies-literature
| S-EPMC3896489 | biostudies-literature
| S-EPMC10514081 | biostudies-literature
| S-EPMC7678296 | biostudies-literature
2022-08-22 | PXD035400 | Pride